USPTO serial 79433175
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medicinal preparations for the treatment of inflammatory and neurodegenerative diseases; medicinal substances, namely, drug capsules and tablets taken orally, drug lotions, creams and unguents given topically | ACTIVE | — |
| 042 | Development of pharmaceutical preparations and medicines; clinical research in the field of inflammatory and neurodegenerative diseases; medical research; pharmaceutical research and development services, namely conducting preclinical research in the field of inflammatory and neurodegenerative diseases | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 29, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 19, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 5, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 5, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 10, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 9, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 28, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 28, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 25, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |